More importantly, we showed that CXCR7 regulated HNSCC cells by increasing autocrine TGF-β1 signaling, suggesting that CXCR7 could be a potential therapeutic target and predictive indicator in HNSCC. Here, TGFB1 is linked to head and neck squamous cell carcinoma.